Ann: OIL March 2024 Quarterly Report and Appendix 4C, page-14

Remember too they already have Convivo working and being sold by CZM. That will generate increasing income as sales start to ramp up and it demonstrates the potential. I just thought about someone I know who has a middle ear tumor in both ears. Now if Convivo was being used in that indication you would think it could have an enormous benefit, and that's outside neurosurgery. I admit that the ENT surgeons involved probably don't know about Convivo even though the Kinevo 900 is likely sitting in another operating theatre in the same institution... All they probably will do is use a normal operating microscope and say the tumour removal is "grossly complete". With the Kinevo-Convivo they they could look at the margin and say with certainty they got it all.